Company: KODK
Filing Date: 2025-05-21
Form Type: 424B5
Source: 0001193125-25-124059
Chunk: 7

Company: EASTMAN KODAK CO
Filing Date: 2025-05-21
Form: 424B5
Chunk 7
---
 price under this offering and, in any event, may not exceed the number of authorized and available shares under our amended and restated certificate of incorporation.                                                              |

| Manner of Offering | Sales, if any, may be made from time to time through or to the Agent as described under the heading “Plan of Distribution” on page S-11. |

| Use of Proceeds | We intend to use the net proceeds from the sale of the securities we may offer by this prospectus for general corporate purposes. Our management will have broad discretion in the use and allocation of net proceeds from the sale of any securities 
 sold by us. See “Use of Proceeds” on page S-5.                                                                                                                                                                                                        |

| New York Stock Exchange symbol | “KODK” |

The number of shares of our common stock that will be outstanding after this offering is based on 80,779,055 shares outstanding as of May 15, 2025 and excludes the shares of common stock reserved for issuance upon the conversion of our preferred stock.

S-2

RISK FACTORS

Investing in our common stock involves a high degree of risk. Before making an investment decision, you should carefully consider the specific factors discussed below, together with all the other information contained in this prospectus supplement, the accompanying prospectus, any free writing prospectus prepared by us or on our behalf we may provide to you in connection with this offering and the documents incorporated and deemed to be incorporated by reference herein and therein. For a further discussion of the risks, uncertainties and assumptions relating to our business, please see the discussion under the caption “Risk Factors” included in our Annual Report on Form 10-Kfor the year ended December 31, 2024, as updated by any other reports and documents we file with the SEC that are incorporated by reference in this prospectus supplement and the accompanying prospectus. The risks described or referenced are not the only risks that we face. Additional risks and uncertainties not currently known to us or that we currently deem immaterial may also impair our business operations. Any of these risks may have a material adverse effect on our business, financial condition, results of operations and cash flows. In such a case, you may lose all or part of your investment in the shares of common stock. In addition, you should consult your own financial and legal advisors before making an investment.

Risks Related to the Offering and Our Common Stock

We will have broad discretion in the use of the net proceeds from this offering and may not use them effectively